Clinical efficacy analysis of thrombolysis combined with anticoagulation therapy for emergency severe pulmonary thromboembolism
溶栓联合抗凝治疗急诊重症肺血栓栓塞症的临床效果分析

摘要

目的 回顾性分析对急诊重症肺血栓栓塞患者应用溶栓联合抗凝治疗的价值。方法 回顾性收集2019年3月-2020年于3月我院就诊的实施了抗凝治疗的急诊重症肺血栓栓塞症30例患者资料为对照组，再回顾性收集2020年4月-2021年于4月于我院实施抗凝联合溶栓治疗的30例患者资料为观察组，对比治疗效果和出血情况；结果 治疗前两组心率、呼吸、肺动脉高压等各项指标差异不显著，p﹥0.05,护理后观察组指标优于对照组，出血率低于对照组，差异显著P﹤0.05。结论 实施溶栓联合抗凝可稳定重症肺血栓栓塞症患者生命体征，提高肺灌注，同时出血率低，治疗安全性有保障。

Abstract

Objective To retrospectively analyze the value of thrombolytic therapy combined with anticoagulation in emergency patients with severe pulmonary thromboembolism.
Methods the data of 30 patients with acute severe pulmonary thromboembolism who received anticoagulant therapy in our hospital from March 2019 to March 2020 were collected retrospectively, the data of 30 patients who received anticoagulation and thrombolytic therapy in our hospital from April 2020 to April 2020 were 2021 as Observation Group
Results before treatment, there was no significant difference in heart rate, respiration and pulmonary hypertension between the two groups (P > 0.05) . After nursing, the indexes in the observation group were better than those in the control group, and the bleeding rate was lower than that in the control group (p < 0.05).
Conclusion   thrombolytic therapy combined with anticoagulation can stabilize the vital signs of patients with severe pulmonary thromboembolism, improve pulmonary perfusion, and reduce the bleeding rate.